Although airway SARS-CoV-2-specific T cell levels tended to be higher in severe cases later in the disease course (>2 weeks post symptom onset (wpo)), this did not reach statistical significance (Fig. 2h,i ).
← all excerpts
Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.
1
—
—